Option chain shows key data for SILO Pharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for SILO Pharma.

SILO Pharma (NASDAQ:SILO) Stock, Option Chain

SILO Pharma

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Palantir, Salesforce, Okta, Meta, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AVNW

BAER

CLDI

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

DTIL

EWCZ

IGMS

INTZ

MVST

Penguin Solutions, Inc. - Ordinary Shares

PENG

SENS

SILO

STAI

VINP

VMAR

XXII

ZCAR

Why Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket

Genetic,Research,And,Biotech,Science,Concept.,Human,Biology,And,Pharmaceutical

Silo Pharma Inc.&#39;s stock (NASDAQ: SILO) is on the the rise Wednesday following the company&#39;s announcement that it has been awarded a U.S. patent for its PTSD treatment titled &#34;Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females.&#34;

Silo Pharma Shares Are Surging Today: What&#39;s Going On?

jobless shutter

Earnings

Equities

Eurozone

Commodities

Intraday Update

ANGO

DATS

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

SANA

XTIA

Crude Oil Down 1%; US Weekly Jobless Claims Decline

SILO Pharma Inc

Silo Wellness Inc

Press Releases

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Health Care

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for  SP-26 Targeting Chronic Pain and Fibromyalgia

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial

Legal

Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment

General

Silo Pharma Granted U.S. Patent for Novel Intranasal Post-Traumatic Stress Disorder Treatment

Silo Pharma Achieves Key Milestone with First Dosing in IND-Enabling GLP Study for SPC-15 as a Groundbreaking PTSD Treatment

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Alzamend Neuro

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

Azitra

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Ensysce Biosciences

GT Biopharma

HCW Biologics

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals

Oragenics

Plus Therapeutics

Palatin Techs

Sunshine Biopharma

Soligenix

Spruce Biosciences

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

Xenetic Biosciences

Laidlaw & Co.

Screenshot 2024-05-21 at 6.46.56 PM

Biotech

ATAI

FTRP

Revolutionizing Mental Healthcare With The Rise Of Ketamine And Psychedelic Therapies

Comments

SILO Pharma

SILO Pharma (SILO) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell